Our findings show that JNK inhibition using the pan-JNK inhibitor SP600125 was effective in inducing cell death in JIMT-1 and BT474-LR resistant cell lines as well as impairing tumor growth of JIMT-1 mammary tumor xenografts. The gene discussed is MAPK8; the disease is breast cancer.